Capital Flow Monitor · Sponsors · CIK 1959576
Aer Therapeutics, Inc.
8 Davis Dr, Research Triangle Park, NC, 27709 · 213-247-8328
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$3.0M
Sold
$3.0M
% sold
100.0%
Investors
7
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-08-19 | D ·current | 506(b) | $3.0M | $3.0M | 100.0% | 7 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Thomas Mathers — Executive Officer / Director, Research Triangle Park, NC
- John Fahy — Director, Research Triangle Park, NC
-
Evan Caplan — Director, Research Triangle Park, NC
2 other raises
- AirNexis Therapeutics, Inc. $62.0M of $200.0M · 31.0%
- Renasant Bio, Inc. $30.0M of $30.0M · 100.0%
- Tim Shannon — Director, Research Triangle Park, NC
-
Christy Shaffer — Director, Research Triangle Park, NC
2 other raises
- Healthcare Innovations Venture Fund, LLC $25.0M of $125.0M · 20.0%
- Hatteras CREATE SF SPV, LLC $737K of $3.0M · 24.6%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.